Bipolar Vaporisation of the Prostate (TURis) in Day-Case Surgery: A Series of 150 Cases
Karim Boularbah
*
Department of Urology, Cheikh Khalifa Hospital, Casablanca, Morocco.
Majid Boutaleb
Department of Urology, Cheikh Khalifa Hospital, Casablanca, Morocco.
Rachid Moussaab
Department of Urology, Cheikh Khalifa Hospital, Casablanca, Morocco.
Younes Houry
Department of Urology, Cheikh Khalifa Hospital, Casablanca, Morocco.
Abdeljalil Heddat
Department of Urology, Cheikh Khalifa Hospital, Casablanca, Morocco.
Ghassane El Omri
Department of Urology, Cheikh Khalifa Hospital, Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Introduction: Benign prostatic hyperplasia (BPH) is a common condition; nearly one third of patients require surgical treatment. Transurethral resection of the prostate (TURP) remains the reference standard, but its morbidity and hospital stay have driven the development of bipolar vaporisation in saline, which may allow same-day discharge.
Objective: The primary objective was to assess the safety (complications graded according to the Clavien-Dindo classification and readmission) of TURis bipolar vaporisation performed as day-case surgery. Secondary objectives were functional outcomes at 1, 3 and 6 months and the feasibility of same-day discharge.
Materials and Methods: This prospective single-centre study included 150 consecutive patients who underwent surgery over a 36-month period at Cheikh Khalifa Hospital, Casablanca. Eligibility for day-case surgery required, among other criteria, a home within 30 km of the hospital and the presence of a caregiver. The International Prostate Symptom Score (IPSS), maximum flow rate (Qmax) and post-void residual volume (PVR) were recorded preoperatively and at 1, 3 and 6 months and compared with baseline using a paired t-test (mean ± SD, 95% CI). Operative time, catheterisation time and complications were recorded.
Results: Mean operative time was 45.3 minutes for a mean prostate volume of 63 g. Two cases of intraoperative haematuria (1.3%) occurred without transfusion. All patients were discharged on the day of surgery. The catheter was removed on postoperative day 1 in 100 patients (66.7%) and on day 2 in 50 (33.3%). Postoperative complications were classified as Clavien-Dindo grades I–II; the readmission rate was 2% and retention after catheter removal occurred in 14.7%. At 6 months, IPSS decreased from 20.3 ± 6.5 to 3.4 ± 1.7 (−83.3%), Qmax increased from 10.8 ± 3.6 to 20.6 ± 2.1 mL/s (+90.7%) and PVR decreased from 134 ± 65 to 18 ± 15.5 mL (−86.6%) (p < 0.001 for each parameter).
Conclusion: In selected patients, day-case TURis bipolar vaporisation was feasible and safe, with significant improvement in symptoms and urinary flow parameters at 6 months. Comparative studies with longer follow-up are needed.
Keywords: Benign prostatic hyperplasia, bipolar vaporisation, TURis, day-case surgery, same-day discharge, transurethral surgery